{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:47:56Z","timestamp":1787510876525,"version":"build-2736575974"},"reference-count":64,"publisher":"American Spinal Injury Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Mouse models of traumatic spinal cord injury (SCI) are used to understand pathophysiology and test potential interventions. Experimental injury parameters, deficits on functional tasks, and histology are used to assess severity and recovery. Blood biomarkers may be a promising additional metric to assess severity and detect efficacy of interventions, but they have not been examined previously in mouse spinal cord injury (SCI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To examine blood biomarkers in mouse SCI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We measured plasma levels of neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) longitudinally following a thoracic contusion SCI in adolescent (3 month old) and aged (18 month old) male and female C57Bl6\/J mice. Biomarkers were also assessed in comparably aged uninjured animals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Three-month-old animals exhibited elevated plasma NfL and GFAP 1 month after injury. NfL levels decreased from 1 to 2 months post injury but remained elevated from baseline, while GFAP levels remained high. Adolescent males exhibited higher NfL levels than females post injury. In aged animals, NfL was comparably elevated at 1 and 2 months post injury. In aged females, GFAP was elevated at 1 and 2 months after injury, while levels in males did not increase from baseline until 2 months after injury. Values from uninjured animals show plasma NfL and GFAP increase with age in absence of injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In a mouse SCI model, plasma NfL and GFAP are elevated chronically after injury. Sex and age at injury may affect biomarker trajectories, which may indicate underlying pathology relevant to treatment and recovery. Establishing the trajectory of NfL and GFAP after experimental injury may help to standardize injury paradigms, assess recovery, and detect efficacy of interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.46292\/sci25-00031","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T03:28:20Z","timestamp":1766114900000},"page":"125-134","source":"Crossref","is-referenced-by-count":1,"title":["Age and Sex Affect the Chronic Trajectory of Plasma Neurofilament Light and Glial Fibrillary Acidic Protein Levels in a Murine Thoracic Contusion Spinal Cord Injury Model"],"prefix":"10.46292","volume":"31","author":[{"given":"Bethany R.","family":"Kondiles","sequence":"first","affiliation":[{"name":"International Collaboration on Repair Discoveries, Vancouver, British Columbia;"},{"name":"Department of Zoology, University of British Columbia, Vancouver, British Columbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjia","family":"Fan","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Hang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Wellington","sequence":"additional","affiliation":[{"name":"International Collaboration on Repair Discoveries, Vancouver, British Columbia;"},{"name":"Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia;"},{"name":"Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Tetzlaff","sequence":"additional","affiliation":[{"name":"International Collaboration on Repair Discoveries, Vancouver, British Columbia;"},{"name":"Department of Zoology, University of British Columbia, Vancouver, British Columbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"25425","reference":[{"issue":"8","key":"b1","series-title":"Spinal Cord","first-page":"714","article-title":"Animal models of spinal cord injury: A systematic review","volume":"55","author":"Sharif-Alhoseini M","year":"2017","unstructured":"Sharif-Alhoseini M, Khormali M, Rezaei M, et al. Animal models of spinal cord injury: A systematic review. Spinal Cord. 2017;55(8):714-721. doi:10.1038\/sc.2016.187."},{"key":"b2","series-title":"Front Neurol.","first-page":"1","article-title":"Traumatic spinal cord injury: An overview of pathophysiology, models and acute injury mechanisms","volume":"10","author":"Alizadeh A","year":"2019","unstructured":"Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Traumatic spinal cord injury: An overview of pathophysiology, models and acute injury mechanisms. Front Neurol. 2019;10(March):1-25. doi:10.3389\/fneur.2019.00282."},{"issue":"1","key":"b3","series-title":"Neurology","first-page":"E40","article-title":"Outcome heterogeneity and bias in acute experimental spinal cord injury: A meta-analysis","volume":"93","author":"Watzlawick R","year":"2019","unstructured":"Watzlawick R, Antonic A, Sena ES, et al. Outcome heterogeneity and bias in acute experimental spinal cord injury: A meta-analysis. Neurology. 2019;93(1):E40-E51. doi:10.1212\/WNL.0000000000007718."},{"issue":"10","key":"b4","series-title":"Spinal Cord","first-page":"819","article-title":"Neurochemical biomarkers in spinal cord injury","volume":"57","author":"Kwon BK","year":"2019","unstructured":"Kwon BK, Bloom O, Wanner IB, et al. Neurochemical biomarkers in spinal cord injury. Spinal Cord. 2019;57(10):819-831. doi:10.1038\/s41393-019-0319-8."},{"key":"b5","series-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource","author":"FDA-NIH Biomarker Working Group","year":"2021","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource. 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK326791\/."},{"issue":"3","key":"b6","series-title":"J Neurol Neurosurg Psychiatry","first-page":"273","article-title":"Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome","volume":"86","author":"Kuhle J","year":"2015","unstructured":"Kuhle J, Gaiottino J, Leppert D, et al. Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome. J Neurol Neurosurg Psychiatry. 2015;86(3):273-279. doi:10.1136\/jnnp-2013-307454."},{"issue":"12","key":"b7","series-title":"Neurology","first-page":"E1221","article-title":"Association of CSF and Serum neurofilament light and glial fibrillary acidic protein, injury severity, and outcome in spinal cord injury","volume":"100","author":"Stukas S","year":"2023","unstructured":"Stukas S, Cooper J, Gill J, et al. Association of CSF and Serum neurofilament light and glial fibrillary acidic protein, injury severity, and outcome in spinal cord injury. Neurology. 2023;100(12):E1221-E1233. doi:10.1212\/WNL.0000000000206744."},{"issue":"6","key":"b8","series-title":"Acta Neurochir (Wien)","first-page":"1417","article-title":"Glial fibrillary acidic protein is a robust biomarker in cerebrospinal fluid and peripheral blood after traumatic spinal cord injury: A prospective pilot study","volume":"165","author":"Wichmann TO","year":"2023","unstructured":"Wichmann TO, Kasch H, Dyrskog S, et al. Glial fibrillary acidic protein is a robust biomarker in cerebrospinal fluid and peripheral blood after traumatic spinal cord injury: A prospective pilot study. Acta Neurochir (Wien). 2023;165(6):1417-1425. doi:10.1007\/s00701-023-05520-x."},{"issue":"3","key":"b9","series-title":"Nat Rev Neurol","first-page":"158","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak A","year":"2022","unstructured":"Abdelhak A, Foschi M, Abu-Rumeileh S, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022;18(3):158-172. doi:10.1038\/s41582-021-00616-3."},{"key":"b10","series-title":"J Neurol Neurosurg Psychiatry","first-page":"870","article-title":"Neurofilament light chain as a biomarker in neurological disorders","author":"Gaetani L","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019:870-881. doi:10.1136\/jnnp-2018-320106."},{"issue":"1","key":"b11","series-title":"Spinal Cord Ser Cases","first-page":"1","article-title":"Acute spinal cord injury serum biomarkers in human and rat: A scoping systematic review","volume":"10","author":"Shool S","year":"2024","unstructured":"Shool S, Rahmani S, Habibi MA, et al. Acute spinal cord injury serum biomarkers in human and rat: A scoping systematic review. Spinal Cord Ser Cases. 2024;10(1):1-20. doi:10.1038\/s41394-024-00636-3."},{"issue":"11","key":"b12","series-title":"Lancet Neurol","first-page":"1026","article-title":"Global, regional, and national burden of spinal cord injury, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"22","author":"Safdarian M","year":"2023","unstructured":"Safdarian M, Trinka E, Rahimi-Movaghar V, et al. Global, regional, and national burden of spinal cord injury, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2023;22(11):1026-1047. doi:10.1016\/S1474-4422(23)00287-9."},{"key":"b13","series-title":"Front Neurol","first-page":"1","article-title":"Considerations for studying sex as a biological variable in spinal cord injury","volume":"11","author":"Stewart AN","year":"2020","unstructured":"Stewart AN, MacLean SM, Stromberg AJ, et al. Considerations for studying sex as a biological variable in spinal cord injury. Front Neurol. 2020;11(August):1-17. doi:10.3389\/fneur.2020.00802."},{"issue":"7","key":"b14","series-title":"PLoS Biol","first-page":"1","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"du Sert NP","year":"2020","unstructured":"du Sert NP, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):1-12. doi:10.1371\/journal.pbio.3000410."},{"issue":"1","key":"b15","series-title":"Nat Commun","article-title":"Locomotor recovery following contusive spinal cord injury does not require oligodendrocyte remyelination","volume":"9","author":"Duncan GJ","year":"2018","unstructured":"Duncan GJ, Manesh SB, Hilton BJ, et al. Locomotor recovery following contusive spinal cord injury does not require oligodendrocyte remyelination. Nat Commun. 2018;9(1). doi:10.1038\/s41467-018-05473-1."},{"issue":"1","key":"b16","series-title":"Alzheimer Res Ther","first-page":"1","article-title":"Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury","volume":"13","author":"Button EB","year":"2021","unstructured":"Button EB, Cheng WH, Barron C, et al. Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury. Alzheimer Res Ther. 2021;13(1):1-27. doi:10.1186\/s13195-021-00793-9."},{"issue":"9","key":"b17","series-title":"Osteoarthr Cartil","first-page":"1159","article-title":"Foundations of osteoarthritis section 3: Clinical monitoring in OA chapter 15: Biomarkers","volume":"30","author":"Kraus VB","year":"2021","unstructured":"Kraus VB, Karsdal MA. Foundations of osteoarthritis section 3: Clinical monitoring in OA chapter 15: Biomarkers. Osteoarthr Cartil. 2021;30(9):1159-1173. doi:10.1016\/j.joca.2021.04.019.Foundations."},{"key":"b18","article-title":"afex: Analysis of Factorial Experiments (Version 1.4-1)","author":"Singmann H","year":"2024","unstructured":"Singmann H, Bolker B, Westfall J, Aust F, Ben-Shachar M. afex: Analysis of Factorial Experiments (Version 1.4-1). 2024. doi:10.32614\/CRAN.package.afex."},{"key":"b19","article-title":"emmeans: Estimated Marginal Means, aka Least-Squares Means (Version 1.11.1)","author":"Lenth R V","year":"2025","unstructured":"Lenth R V. emmeans: Estimated Marginal Means, aka Least-Squares Means (Version 1.11.1). 2025. doi:10.32614\/CRAN.package.emmeans."},{"issue":"1","key":"b20","series-title":"J Transl Med","first-page":"1","article-title":"Can harmonisation of outcomes bridge the translation gap for pre-clinical research? A systematic review of outcomes measured in mouse models of type 2 diabetes","volume":"18","author":"Harman NL","year":"2020","unstructured":"Harman NL, Sanz-Moreno A, Papoutsopoulou S, et al. Can harmonisation of outcomes bridge the translation gap for pre-clinical research? A systematic review of outcomes measured in mouse models of type 2 diabetes. J Transl Med. 2020;18(1):1-12. doi:10.1186\/s12967-020-02649-6."},{"issue":"6","key":"b21","series-title":"J Neurotrauma","first-page":"831","article-title":"FAIR SCI ahead: The Evolution of the open data commons for pre-clinical spinal cord injury research","volume":"37","author":"Fouad K","year":"2020","unstructured":"Fouad K, Bixby JL, Callahan A, et al. FAIR SCI ahead: The Evolution of the open data commons for pre-clinical spinal cord injury research. J Neurotrauma. 2020;37(6):831-838. doi:10.1089\/neu.2019.6674."},{"issue":"3","key":"b22","series-title":"Mol Neurobiol","first-page":"2174","article-title":"Temporal profile and severity correlation of a panel of rat spinal cord injury protein biomarkers","volume":"55","author":"Yang Z","year":"2018","unstructured":"Yang Z, Bramlett HM, Moghieb A, et al. Temporal profile and severity correlation of a panel of rat spinal cord injury protein biomarkers. Mol Neurobiol. 2018;55(3):2174-2184. doi:10.1007\/s12035-017-0424-7."},{"issue":"3","key":"b23","series-title":"Spinal Cord","first-page":"333","article-title":"Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury","volume":"49","author":"Ueno T","year":"2011","unstructured":"Ueno T, Ohori Y, Ito J, et al. Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury. Spinal Cord. 2011;49(3):333-336. doi:10.1038\/sc.2010.116."},{"key":"b24","series-title":"Front Aging Neurosci","first-page":"1","article-title":"Dynamic diversity of glial response among species in spinal cord injury","volume":"13","author":"Perez JC","year":"2021","unstructured":"Perez JC, Gerber YN, Perrin FE. Dynamic diversity of glial response among species in spinal cord injury. Front Aging Neurosci. 2021;13(Nov):1-16. doi:10.3389\/fnagi.2021.769548."},{"issue":"24","key":"b25","series-title":"Aging (Albany NY)","first-page":"25729","article-title":"Factors influencing sNFL levels in normal aging","volume":"13","author":"Koini M","year":"2021","unstructured":"Koini M, Pirpamer L, Hofer E, et al. Factors influencing sNFL levels in normal aging. Aging (Albany NY). 2021;13(24):25729-25738. doi:10.18632\/aging.203790."},{"key":"b26","series-title":"Clin Biochem","first-page":"110680","article-title":"Age specific reference intervals for plasma biomarkers of neurodegeneration and neurotrauma in a Canadian population","volume":"121-122","author":"Cooper JG","year":"2023","unstructured":"Cooper JG, Stukas S, Ghodsi M, et al. Age specific reference intervals for plasma biomarkers of neurodegeneration and neurotrauma in a Canadian population. Clin Biochem. 2023;121-122(Aug):110680. doi:10.1016\/j.clinbiochem.2023.110680."},{"issue":"8","key":"b27","series-title":"PLoS One","first-page":"1","article-title":"Levels and age dependency of neurofilament light and Glial Fibrillary Acidic Protein in healthy individuals and their relation to the brain parenchymal fraction","volume":"10","author":"V\u00e5gberg M","year":"2015","unstructured":"V\u00e5gberg M, Norgren N, Dring A, et al. Levels and age dependency of neurofilament light and Glial Fibrillary Acidic Protein in healthy individuals and their relation to the brain parenchymal fraction. PLoS One. 2015;10(8):1-8. doi:10.1371\/journal.pone.0135886."},{"issue":"16","key":"b28","series-title":"J Neurotrauma","first-page":"2400","article-title":"Serum neurofilament light is elevated differentially in older adults with uncomplicated mild traumatic brain injuries","volume":"36","author":"Iverson GL","year":"2019","unstructured":"Iverson GL, Reddi PJ, Posti JP, et al. Serum neurofilament light is elevated differentially in older adults with uncomplicated mild traumatic brain injuries. J Neurotrauma. 2019;36(16):2400-2406. doi:10.1089\/neu.2018.6341."},{"issue":"2-3","key":"b29","series-title":"Physiol Behav","first-page":"351","article-title":"Importance of fighting in the immune effects of social defeat","volume":"80","author":"Merlot E","year":"2003","unstructured":"Merlot E, Moze E, Dantzer R, Neveu PJ. Importance of fighting in the immune effects of social defeat. Physiol Behav. 2003;80(2-3):351-357. doi:10.1016\/j.physbeh.2003.08.005."},{"key":"b30","series-title":"Front Behav Neurosci","first-page":"1","article-title":"Behavior and pro-inflammatory cytokine variations among submissive and dominant mice engaged in aggressive encounters: Moderation by corticosterone reactivity","volume":"4","author":"Audet MC","year":"2010","unstructured":"Audet MC, Mangano EN, Anisman H. Behavior and pro-inflammatory cytokine variations among submissive and dominant mice engaged in aggressive encounters: Moderation by corticosterone reactivity. Front Behav Neurosci. 2010;4(AUG):1-12. doi:10.3389\/fnbeh.2010.00156."},{"key":"b31","series-title":"Biomark Insights","first-page":"15","article-title":"Serum neurofilament light as a biomarker of traumatic brain injury in the presence of concomitant peripheral injury","volume":"16","author":"Wong KR","year":"2021","unstructured":"Wong KR, O\u2019Brien WT, Sun M, et al. Serum neurofilament light as a biomarker of traumatic brain injury in the presence of concomitant peripheral injury. Biomark Insights. 2021;16:15-18. doi:10.1177\/11772719211053449."},{"issue":"3","key":"b32","series-title":"Neurobiol Aging","first-page":"434","article-title":"Is age a key determinant of mortality and neurological outcome after acute traumatic spinal cord injury?","volume":"31","author":"Furlan JC","year":"2010","unstructured":"Furlan JC, Bracken MB, Fehlings MG. Is age a key determinant of mortality and neurological outcome after acute traumatic spinal cord injury? Neurobiol Aging. 2010;31(3):434-446. doi:10.1016\/j.neurobiolaging.2008.05.003."},{"issue":"8","key":"b1","series-title":"Spinal Cord","first-page":"714","article-title":"Animal models of spinal cord injury: A systematic review","volume":"55","author":"Sharif-Alhoseini M","year":"2017","unstructured":"Sharif-Alhoseini M, Khormali M, Rezaei M, et al. Animal models of spinal cord injury: A systematic review. Spinal Cord. 2017;55(8):714-721. doi:10.1038\/sc.2016.187."},{"key":"b2","series-title":"Front Neurol.","first-page":"1","article-title":"Traumatic spinal cord injury: An overview of pathophysiology, models and acute injury mechanisms","volume":"10","author":"Alizadeh A","year":"2019","unstructured":"Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Traumatic spinal cord injury: An overview of pathophysiology, models and acute injury mechanisms. Front Neurol. 2019;10(March):1-25. doi:10.3389\/fneur.2019.00282."},{"issue":"1","key":"b3","series-title":"Neurology","first-page":"E40","article-title":"Outcome heterogeneity and bias in acute experimental spinal cord injury: A meta-analysis","volume":"93","author":"Watzlawick R","year":"2019","unstructured":"Watzlawick R, Antonic A, Sena ES, et al. Outcome heterogeneity and bias in acute experimental spinal cord injury: A meta-analysis. Neurology. 2019;93(1):E40-E51. doi:10.1212\/WNL.0000000000007718."},{"issue":"10","key":"b4","series-title":"Spinal Cord","first-page":"819","article-title":"Neurochemical biomarkers in spinal cord injury","volume":"57","author":"Kwon BK","year":"2019","unstructured":"Kwon BK, Bloom O, Wanner IB, et al. Neurochemical biomarkers in spinal cord injury. Spinal Cord. 2019;57(10):819-831. doi:10.1038\/s41393-019-0319-8."},{"key":"b5","series-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource","author":"FDA-NIH Biomarker Working Group","year":"2021","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource. 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK326791\/."},{"issue":"3","key":"b6","series-title":"J Neurol Neurosurg Psychiatry","first-page":"273","article-title":"Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome","volume":"86","author":"Kuhle J","year":"2015","unstructured":"Kuhle J, Gaiottino J, Leppert D, et al. Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome. J Neurol Neurosurg Psychiatry. 2015;86(3):273-279. doi:10.1136\/jnnp-2013-307454."},{"issue":"12","key":"b7","series-title":"Neurology","first-page":"E1221","article-title":"Association of CSF and Serum neurofilament light and glial fibrillary acidic protein, injury severity, and outcome in spinal cord injury","volume":"100","author":"Stukas S","year":"2023","unstructured":"Stukas S, Cooper J, Gill J, et al. Association of CSF and Serum neurofilament light and glial fibrillary acidic protein, injury severity, and outcome in spinal cord injury. Neurology. 2023;100(12):E1221-E1233. doi:10.1212\/WNL.0000000000206744."},{"issue":"6","key":"b8","series-title":"Acta Neurochir (Wien)","first-page":"1417","article-title":"Glial fibrillary acidic protein is a robust biomarker in cerebrospinal fluid and peripheral blood after traumatic spinal cord injury: A prospective pilot study","volume":"165","author":"Wichmann TO","year":"2023","unstructured":"Wichmann TO, Kasch H, Dyrskog S, et al. Glial fibrillary acidic protein is a robust biomarker in cerebrospinal fluid and peripheral blood after traumatic spinal cord injury: A prospective pilot study. Acta Neurochir (Wien). 2023;165(6):1417-1425. doi:10.1007\/s00701-023-05520-x."},{"issue":"3","key":"b9","series-title":"Nat Rev Neurol","first-page":"158","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak A","year":"2022","unstructured":"Abdelhak A, Foschi M, Abu-Rumeileh S, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022;18(3):158-172. doi:10.1038\/s41582-021-00616-3."},{"key":"b10","series-title":"J Neurol Neurosurg Psychiatry","first-page":"870","article-title":"Neurofilament light chain as a biomarker in neurological disorders","author":"Gaetani L","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019:870-881. doi:10.1136\/jnnp-2018-320106."},{"issue":"1","key":"b11","series-title":"Spinal Cord Ser Cases","first-page":"1","article-title":"Acute spinal cord injury serum biomarkers in human and rat: A scoping systematic review","volume":"10","author":"Shool S","year":"2024","unstructured":"Shool S, Rahmani S, Habibi MA, et al. Acute spinal cord injury serum biomarkers in human and rat: A scoping systematic review. Spinal Cord Ser Cases. 2024;10(1):1-20. doi:10.1038\/s41394-024-00636-3."},{"issue":"11","key":"b12","series-title":"Lancet Neurol","first-page":"1026","article-title":"Global, regional, and national burden of spinal cord injury, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"22","author":"Safdarian M","year":"2023","unstructured":"Safdarian M, Trinka E, Rahimi-Movaghar V, et al. Global, regional, and national burden of spinal cord injury, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2023;22(11):1026-1047. doi:10.1016\/S1474-4422(23)00287-9."},{"key":"b13","series-title":"Front Neurol","first-page":"1","article-title":"Considerations for studying sex as a biological variable in spinal cord injury","volume":"11","author":"Stewart AN","year":"2020","unstructured":"Stewart AN, MacLean SM, Stromberg AJ, et al. Considerations for studying sex as a biological variable in spinal cord injury. Front Neurol. 2020;11(August):1-17. doi:10.3389\/fneur.2020.00802."},{"issue":"7","key":"b14","series-title":"PLoS Biol","first-page":"1","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"du Sert NP","year":"2020","unstructured":"du Sert NP, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):1-12. doi:10.1371\/journal.pbio.3000410."},{"issue":"1","key":"b15","series-title":"Nat Commun","article-title":"Locomotor recovery following contusive spinal cord injury does not require oligodendrocyte remyelination","volume":"9","author":"Duncan GJ","year":"2018","unstructured":"Duncan GJ, Manesh SB, Hilton BJ, et al. Locomotor recovery following contusive spinal cord injury does not require oligodendrocyte remyelination. Nat Commun. 2018;9(1). doi:10.1038\/s41467-018-05473-1."},{"issue":"1","key":"b16","series-title":"Alzheimer Res Ther","first-page":"1","article-title":"Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury","volume":"13","author":"Button EB","year":"2021","unstructured":"Button EB, Cheng WH, Barron C, et al. Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury. Alzheimer Res Ther. 2021;13(1):1-27. doi:10.1186\/s13195-021-00793-9."},{"issue":"9","key":"b17","series-title":"Osteoarthr Cartil","first-page":"1159","article-title":"Foundations of osteoarthritis section 3: Clinical monitoring in OA chapter 15: Biomarkers","volume":"30","author":"Kraus VB","year":"2021","unstructured":"Kraus VB, Karsdal MA. Foundations of osteoarthritis section 3: Clinical monitoring in OA chapter 15: Biomarkers. Osteoarthr Cartil. 2021;30(9):1159-1173. doi:10.1016\/j.joca.2021.04.019.Foundations."},{"key":"b18","article-title":"afex: Analysis of Factorial Experiments (Version 1.4-1)","author":"Singmann H","year":"2024","unstructured":"Singmann H, Bolker B, Westfall J, Aust F, Ben-Shachar M. afex: Analysis of Factorial Experiments (Version 1.4-1). 2024. doi:10.32614\/CRAN.package.afex."},{"key":"b19","article-title":"emmeans: Estimated Marginal Means, aka Least-Squares Means (Version 1.11.1)","author":"Lenth R V","year":"2025","unstructured":"Lenth R V. emmeans: Estimated Marginal Means, aka Least-Squares Means (Version 1.11.1). 2025. doi:10.32614\/CRAN.package.emmeans."},{"issue":"1","key":"b20","series-title":"J Transl Med","first-page":"1","article-title":"Can harmonisation of outcomes bridge the translation gap for pre-clinical research? A systematic review of outcomes measured in mouse models of type 2 diabetes","volume":"18","author":"Harman NL","year":"2020","unstructured":"Harman NL, Sanz-Moreno A, Papoutsopoulou S, et al. Can harmonisation of outcomes bridge the translation gap for pre-clinical research? A systematic review of outcomes measured in mouse models of type 2 diabetes. J Transl Med. 2020;18(1):1-12. doi:10.1186\/s12967-020-02649-6."},{"issue":"6","key":"b21","series-title":"J Neurotrauma","first-page":"831","article-title":"FAIR SCI ahead: The Evolution of the open data commons for pre-clinical spinal cord injury research","volume":"37","author":"Fouad K","year":"2020","unstructured":"Fouad K, Bixby JL, Callahan A, et al. FAIR SCI ahead: The Evolution of the open data commons for pre-clinical spinal cord injury research. J Neurotrauma. 2020;37(6):831-838. doi:10.1089\/neu.2019.6674."},{"issue":"3","key":"b22","series-title":"Mol Neurobiol","first-page":"2174","article-title":"Temporal profile and severity correlation of a panel of rat spinal cord injury protein biomarkers","volume":"55","author":"Yang Z","year":"2018","unstructured":"Yang Z, Bramlett HM, Moghieb A, et al. Temporal profile and severity correlation of a panel of rat spinal cord injury protein biomarkers. Mol Neurobiol. 2018;55(3):2174-2184. doi:10.1007\/s12035-017-0424-7."},{"issue":"3","key":"b23","series-title":"Spinal Cord","first-page":"333","article-title":"Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury","volume":"49","author":"Ueno T","year":"2011","unstructured":"Ueno T, Ohori Y, Ito J, et al. Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury. Spinal Cord. 2011;49(3):333-336. doi:10.1038\/sc.2010.116."},{"key":"b24","series-title":"Front Aging Neurosci","first-page":"1","article-title":"Dynamic diversity of glial response among species in spinal cord injury","volume":"13","author":"Perez JC","year":"2021","unstructured":"Perez JC, Gerber YN, Perrin FE. Dynamic diversity of glial response among species in spinal cord injury. Front Aging Neurosci. 2021;13(Nov):1-16. doi:10.3389\/fnagi.2021.769548."},{"issue":"24","key":"b25","series-title":"Aging (Albany NY)","first-page":"25729","article-title":"Factors influencing sNFL levels in normal aging","volume":"13","author":"Koini M","year":"2021","unstructured":"Koini M, Pirpamer L, Hofer E, et al. Factors influencing sNFL levels in normal aging. Aging (Albany NY). 2021;13(24):25729-25738. doi:10.18632\/aging.203790."},{"key":"b26","series-title":"Clin Biochem","first-page":"110680","article-title":"Age specific reference intervals for plasma biomarkers of neurodegeneration and neurotrauma in a Canadian population","volume":"121-122","author":"Cooper JG","year":"2023","unstructured":"Cooper JG, Stukas S, Ghodsi M, et al. Age specific reference intervals for plasma biomarkers of neurodegeneration and neurotrauma in a Canadian population. Clin Biochem. 2023;121-122(Aug):110680. doi:10.1016\/j.clinbiochem.2023.110680."},{"issue":"8","key":"b27","series-title":"PLoS One","first-page":"1","article-title":"Levels and age dependency of neurofilament light and Glial Fibrillary Acidic Protein in healthy individuals and their relation to the brain parenchymal fraction","volume":"10","author":"V\u00e5gberg M","year":"2015","unstructured":"V\u00e5gberg M, Norgren N, Dring A, et al. Levels and age dependency of neurofilament light and Glial Fibrillary Acidic Protein in healthy individuals and their relation to the brain parenchymal fraction. PLoS One. 2015;10(8):1-8. doi:10.1371\/journal.pone.0135886."},{"issue":"16","key":"b28","series-title":"J Neurotrauma","first-page":"2400","article-title":"Serum neurofilament light is elevated differentially in older adults with uncomplicated mild traumatic brain injuries","volume":"36","author":"Iverson GL","year":"2019","unstructured":"Iverson GL, Reddi PJ, Posti JP, et al. Serum neurofilament light is elevated differentially in older adults with uncomplicated mild traumatic brain injuries. J Neurotrauma. 2019;36(16):2400-2406. doi:10.1089\/neu.2018.6341."},{"issue":"2-3","key":"b29","series-title":"Physiol Behav","first-page":"351","article-title":"Importance of fighting in the immune effects of social defeat","volume":"80","author":"Merlot E","year":"2003","unstructured":"Merlot E, Moze E, Dantzer R, Neveu PJ. Importance of fighting in the immune effects of social defeat. Physiol Behav. 2003;80(2-3):351-357. doi:10.1016\/j.physbeh.2003.08.005."},{"key":"b30","series-title":"Front Behav Neurosci","first-page":"1","article-title":"Behavior and pro-inflammatory cytokine variations among submissive and dominant mice engaged in aggressive encounters: Moderation by corticosterone reactivity","volume":"4","author":"Audet MC","year":"2010","unstructured":"Audet MC, Mangano EN, Anisman H. Behavior and pro-inflammatory cytokine variations among submissive and dominant mice engaged in aggressive encounters: Moderation by corticosterone reactivity. Front Behav Neurosci. 2010;4(AUG):1-12. doi:10.3389\/fnbeh.2010.00156."},{"key":"b31","series-title":"Biomark Insights","first-page":"15","article-title":"Serum neurofilament light as a biomarker of traumatic brain injury in the presence of concomitant peripheral injury","volume":"16","author":"Wong KR","year":"2021","unstructured":"Wong KR, O\u2019Brien WT, Sun M, et al. Serum neurofilament light as a biomarker of traumatic brain injury in the presence of concomitant peripheral injury. Biomark Insights. 2021;16:15-18. doi:10.1177\/11772719211053449."},{"issue":"3","key":"b32","series-title":"Neurobiol Aging","first-page":"434","article-title":"Is age a key determinant of mortality and neurological outcome after acute traumatic spinal cord injury?","volume":"31","author":"Furlan JC","year":"2010","unstructured":"Furlan JC, Bracken MB, Fehlings MG. Is age a key determinant of mortality and neurological outcome after acute traumatic spinal cord injury? Neurobiol Aging. 2010;31(3):434-446. doi:10.1016\/j.neurobiolaging.2008.05.003."}],"container-title":["Topics in Spinal Cord Injury Rehabilitation"],"original-title":[],"link":[{"URL":"https:\/\/tscir.kglmeridian.com\/view\/journals\/tscr\/31\/2\/article-p125.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/tscir\/article-pdf\/31\/2\/125\/3548228\/i1945-5763-31-2-125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/tscir.kglmeridian.com\/downloadpdf\/journals\/tscr\/31\/2\/article-p125.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/tscir.kglmeridian.com\/downloadpdf\/journals\/tscr\/31\/2\/article-p125.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:50:58Z","timestamp":1775145058000},"score":1,"resource":{"primary":{"URL":"https:\/\/tscir.kglmeridian.com\/view\/journals\/tscr\/31\/2\/article-p125.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":64,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.46292\/sci25-00031","relation":{},"ISSN":["1082-0744","1945-5763"],"issn-type":[{"value":"1082-0744","type":"print"},{"value":"1945-5763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}